Fleet Bioprocessing Ltd. are proud to report that we received zero non-conformances in our latest audit against the requirements of ISO9001: 2015 and ISO13485: 2016, which was carried out by NQA in December.
top of page
Recent Posts
See AllRecently, one of Fleet Bioprocessing’s experts was asked to consult on a project. Nothing unusual about that, Fleet experts regularly act as consultants for clients advising on bioconjugation, ELISA a
One of the most notable recent innovations in the field of medical science is the development of Antibody-Drug Conjugates (ADCs). ADCs represent a revolutionary approach in cancer treatment, marrying
At Fleet Bioprocessing Ltd., we take pride in being a Gyrolab Certified Assay Transfer and Development Partner. Fleet Bioprocessing Ltd. enjoys global recognition for our proficiency in bioconjugation
bottom of page